Video
2022 recap: Dr. Chi highlights milestones in stone disease
Author(s):
“We've got a lot of movement in terms of understanding how stones form, some pharmaceutical interventions that we can use to prevent stones, and then how we can get even less invasive to try to get stones in the least morbid way for our patients,” says Thomas Chi, MD.
Video Player is loading.
Urology Times® is wrapping up the year by diving into some milestones from different urologic specialties. In this interview, Thomas Chi, MD, recaps some of the clinical and research highlights in stone disease from the past year. Chi is a professor and associate chair at the University of California, San Francisco.
Related Videos
Ian Metzler, MD, highlights recent advances in kidney stone technology
Sima Porten, MD, on gene-environment interactions in bladder cancer development
Hailey Frye discusses improvement of pain management for nephrolithiasis
Ian Metzler, MD, on the increasing prevalence of kidney stones in women
How pre-URS tamsulosin use in pediatric patients may reduce repeat procedures
Expert discusses innovations in single-use ureteroscopes for stones
Sima Porten, MD, discusses the need to educate on the firefighter-bladder cancer link
Investigators evaluate tamsulosin use in pediatric patients
Pain management disparities in kidney stones point to need for guidelines, experts say
Perry Xu, MD, on the potential of AI in the endourology space
Related Content
May 23rd 2022
